Legal Representation
Attorney
Viviana Amzel, Esq.
USPTO Deadlines
Application History
31 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 7, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Sep 7, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Dec 29, 2005 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
Dec 29, 2005 | EXT5 | S | EXTENSION 5 FILED | Loading... |
Dec 29, 2005 | EX5G | S | EXTENSION 5 GRANTED | Loading... |
Jul 1, 2005 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
Jul 1, 2005 | EXT4 | S | EXTENSION 4 FILED | Loading... |
Jul 1, 2005 | EX4G | S | EXTENSION 4 GRANTED | Loading... |
Jan 10, 2005 | EX3G | S | EXTENSION 3 GRANTED | Loading... |
Dec 23, 2004 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
Dec 23, 2004 | EXT3 | S | EXTENSION 3 FILED | Loading... |
Jul 28, 2004 | EX2G | S | EXTENSION 2 GRANTED | Loading... |
Jul 19, 2004 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 16, 2004 | I | PAPER RECEIVED | Loading... | |
Jul 12, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
Jun 30, 2004 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
Jun 30, 2004 | EXT2 | S | EXTENSION 2 FILED | Loading... |
Jan 22, 2004 | EX1G | S | EXTENSION 1 GRANTED | Loading... |
Dec 31, 2003 | EEXT | I | TEAS EXTENSION RECEIVED | Loading... |
Dec 31, 2003 | EXT1 | S | EXTENSION 1 FILED | Loading... |
Jul 1, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 8, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 19, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Jan 29, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 25, 2002 | I | PAPER RECEIVED | Loading... | |
Oct 25, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 25, 2002 | 1.AD | I | SEC. 1(A) CLAIM DELETED | Loading... |
Oct 25, 2002 | 1.BA | I | Sec. 1(B) CLAIM ADDED | Loading... |
Apr 26, 2002 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Apr 8, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 4, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
medical diagnostic and therapeutic preparations and devices for administering same, sold filled with diagnostic and therapeutic preparations or separately as a kit, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled or separately as a kit, the preparations including polynucleotides, proteins and/or organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms,; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g.; cancers which metastasized to the lung(s), breast, liver and prostate included
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
EPI GENESIS PHARMACEUTICALS DOT COM
Classification
International Classes
005